BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1850526)

  • 1. Activation of peritoneal macrophages by orally administered ether analogues of lysophospholipids.
    Ngwenya BZ; Fiavey NP; Mogashoa MM
    Proc Soc Exp Biol Med; 1991 May; 197(1):91-7. PubMed ID: 1850526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-neoplastic action of peritoneal macrophages following oral administration of ether analogues of lysophospholipids.
    Ngwenya BZ; Fiavey NP; Mogashoa MM
    Eur J Cancer; 1992; 28A(10):1637-42. PubMed ID: 1389479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of macrophages by ether analogues of lysophospholipids.
    Yamamoto N; Ngwenya BZ; Sery TW; Pieringer RA
    Cancer Immunol Immunother; 1987; 25(3):185-92. PubMed ID: 2824051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues.
    Yamamoto N; St Claire DA; Homma S; Ngwenya BZ
    Cancer Res; 1988 Nov; 48(21):6044-9. PubMed ID: 3167855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of mouse peritoneal macrophages by lysophospholipids and ether derivatives of neutral lipids and phospholipids.
    Yamamoto N; Ngwenya BZ
    Cancer Res; 1987 Apr; 47(8):2008-13. PubMed ID: 2950993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A serum factor for macrophage activation after in vitro dodecylglycerol treatment of mouse lymphocytes.
    Homma S; Millman I; Yamamoto N
    Immunol Cell Biol; 1990 Apr; 68 ( Pt 2)():137-42. PubMed ID: 1696561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation process of macrophages after in vitro treatment of mouse lymphocytes with dodecylglycerol.
    Homma S; Yamamoto N
    Clin Exp Immunol; 1990 Feb; 79(2):307-13. PubMed ID: 2178824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of serum proteins in the inflammation-primed activation of macrophages.
    Yamamoto N; Willett NP; Lindsay DD
    Inflammation; 1994 Jun; 18(3):311-22. PubMed ID: 8088927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells.
    Yamamoto N; Homma S; Haddad JG; Kowalski MA
    Immunology; 1991 Nov; 74(3):420-4. PubMed ID: 1769691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of antibody production by lysophosphatidylcholine and alkylglycerol.
    Ngwenya BZ; Foster DM
    Proc Soc Exp Biol Med; 1991 Jan; 196(1):69-75. PubMed ID: 1984244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superoxide production by macrophages stimulated in vivo with synthetic ether lipids.
    Schreiber BM; Layne MD; Modest EJ
    Lipids; 1994 Apr; 29(4):237-42. PubMed ID: 8177017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory and therapeutic properties of alkyl lysophospholipids in mice.
    Talmadge JE; Schneider M; Lenz B; Phillips H; Long C
    Lipids; 1987 Nov; 22(11):871-7. PubMed ID: 3502167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidylcholine attenuates the cytotoxic effects of the antineoplastic phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3- phosphocholine.
    Boggs KP; Rock CO; Jackowski S
    J Biol Chem; 1995 May; 270(19):11612-8. PubMed ID: 7744800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
    Unger C; Eibl H; Kim DJ; Fleer EA; Kötting J; Bartsch HH; Nagel GA; Pfizenmaier K
    J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of orally administered rac-1-O-[1'-14C]dodecylglycerol and nutritional effects of dietary rac-1-O-dodecylglycerol in mice.
    Weber N
    J Lipid Res; 1985 Dec; 26(12):1412-20. PubMed ID: 4086944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased membrane permeability for an antitumoral alkyl lysophospholipid in sensitive tumor cells.
    Storch J; Munder PG
    Lipids; 1987 Nov; 22(11):813-9. PubMed ID: 3444371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of c-Jun NH2-terminal kinase activation and c-Jun in the induction of apoptosis by the ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Gajate C; Santos-Beneit A; Modolell M; Mollinedo F
    Mol Pharmacol; 1998 Apr; 53(4):602-12. PubMed ID: 9547349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and selective induction of apoptosis in human leukemic cells by the alkyl-lysophospholipid ET-18-OCH3.
    Mollinedo F; Martínez-Dalmau R; Modolell M
    Biochem Biophys Res Commun; 1993 Apr; 192(2):603-9. PubMed ID: 8484770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
    Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ
    Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties.
    Houlihan WJ; Lee ML; Munder PG; Winslow CM; Cheon SH; D'Aries FJ; DeLillo AK; Jaeggi CS; Mason RB; Parrino VA
    J Lipid Mediat; 1990; 2(5):295-307. PubMed ID: 2133273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.